<?xml version="1.0" encoding="UTF-8"?>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" dtd-version="1.0" article-type="reference-list">
<front>
<article-meta>
<custom-meta-group>
<custom-meta><meta-name>TotalReferences</meta-name><meta-value>32</meta-value></custom-meta>
<custom-meta><meta-name>ReferencesParsed</meta-name><meta-value>29</meta-value></custom-meta>
<custom-meta><meta-name>ReferencesBillable</meta-name><meta-value>30</meta-value></custom-meta>
<custom-meta><meta-name>LinkServices</meta-name><meta-value>pubmed-crossref</meta-value></custom-meta>
<custom-meta><meta-name>ReferencesLinked</meta-name><meta-value>26</meta-value></custom-meta>
<custom-meta><meta-name>ReferencesLinkedDOI</meta-name><meta-value>22</meta-value></custom-meta>
<custom-meta><meta-name>ReferencesLinkedPMID</meta-name><meta-value>25</meta-value></custom-meta>
<custom-meta><meta-name>JournalReferences</meta-name><meta-value>26</meta-value></custom-meta>
<custom-meta><meta-name>BookReferences</meta-name><meta-value>1</meta-value></custom-meta>
<custom-meta><meta-name>BookChapterReferences</meta-name><meta-value>3</meta-value></custom-meta>
<custom-meta><meta-name>ConferenceReferences</meta-name><meta-value>0</meta-value></custom-meta>
<custom-meta><meta-name>ElectronicReferences</meta-name><meta-value>0</meta-value></custom-meta>
<custom-meta><meta-name>DissertationReferences</meta-name><meta-value>0</meta-value></custom-meta>
<custom-meta><meta-name>LegalReferences</meta-name><meta-value>0</meta-value></custom-meta>
<custom-meta><meta-name>StandardReferences</meta-name><meta-value>0</meta-value></custom-meta>
<custom-meta><meta-name>OtherReferences</meta-name><meta-value>0</meta-value></custom-meta>
<custom-meta><meta-name>UnknownReferences</meta-name><meta-value>2</meta-value></custom-meta>
<custom-meta><meta-name>ReferencesSemiParsed</meta-name><meta-value>0</meta-value></custom-meta>
<custom-meta><meta-name>ReferencesBookUnparsed</meta-name><meta-value>1</meta-value></custom-meta>
<custom-meta><meta-name>EditorialStyle</meta-name><meta-value>ICMJE-WHO</meta-value></custom-meta>
</custom-meta-group>
</article-meta>
</front>
<back>
<ref-list>
<ref id="b1"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Fani</surname> <given-names>M</given-names></string-name>, <string-name><surname>Maecke</surname> <given-names>HR</given-names></string-name></person-group>. <article-title>Radiopharmaceutical development of radiolabelled peptides</article-title>. <source>Eur J Nucl Med Mol Imaging</source>. <year>2012</year> <month>Feb</month>;<volume>39</volume>(<issue>1</issue> <supplement>Suppl 1</supplement>):<fpage>S11</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1007/s00259-011-2001-z</pub-id><pub-id pub-id-type="pmid">22388624</pub-id><issn>1619-7070</issn></mixed-citation></ref>
<ref id="b2"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Aloj</surname> <given-names>L</given-names></string-name>, <string-name><surname>Panico</surname> <given-names>MR</given-names></string-name>, <string-name><surname>Caracó</surname> <given-names>C</given-names></string-name>, <string-name><surname>Zannetti</surname> <given-names>A</given-names></string-name>, <string-name><surname>Del Vecchio</surname> <given-names>S</given-names></string-name>, <string-name><surname>Di Nuzzo</surname> <given-names>C</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Radiolabeling approaches for cholecystokinin B receptor imaging</article-title>. <source>Biopolymers</source>. <year>2002</year>;<volume>66</volume>(<issue>6</issue>):<fpage>370</fpage>–<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1002/bip.10347</pub-id><pub-id pub-id-type="pmid">12658724</pub-id><issn>0006-3525</issn></mixed-citation></ref>
<ref id="b3"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Dash</surname> <given-names>A</given-names></string-name>, <string-name><surname>Chakraborty</surname> <given-names>S</given-names></string-name>, <string-name><surname>Pillai</surname> <given-names>MR</given-names></string-name>, <string-name><surname>Knapp</surname> <given-names>FF</given-names> <suffix>Jr</suffix></string-name></person-group>. <article-title>Peptide receptor radionuclide therapy: an overview</article-title>. <source>Cancer Biother Radiopharm</source>. <year>2015</year> <month>Mar</month>;<volume>30</volume>(<issue>2</issue>):<fpage>47</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1089/cbr.2014.1741</pub-id><pub-id pub-id-type="pmid">25710506</pub-id><issn>1084-9785</issn></mixed-citation></ref>
<ref id="b4"><mixed-citation publication-type="book-chapter" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Cremonesi</surname> <given-names>M</given-names></string-name>, <string-name><surname>Schuchardt</surname> <given-names>C</given-names></string-name></person-group>. <chapter-title>Dosimetry for Peptide Receptor Radionuclide Therapy</chapter-title>. <source>Baum RP, ur. Therapeutic Nuclear Medicine</source>. <publisher-name>Springer</publisher-name>; <year>2014</year>. pp. <fpage>769</fpage>–<lpage>79</lpage>.</mixed-citation></ref>
<ref id="b5"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Baum</surname> <given-names>RP</given-names></string-name>, <string-name><surname>Kulkarni</surname> <given-names>HR</given-names></string-name></person-group>. <article-title>Theranostics: from molecular imaging using Ga-68 labeled tracers and PET/CT to personalized radionuclide therapy-the Bad Berka experience</article-title>. <source>Theranostics</source>. <year>2012</year>;<volume>2</volume>(<issue>5</issue>):<fpage>437</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.7150/thno.3645</pub-id><pub-id pub-id-type="pmid">22768024</pub-id><issn>1838-7640</issn></mixed-citation></ref>
<ref id="b6"><mixed-citation publication-type="book-chapter" specific-use="unparsed"><person-group person-group-type="author"><string-name><surname>Ležaić</surname> <given-names>L</given-names></string-name>, <string-name><surname>Fettich</surname> <given-names>J</given-names></string-name></person-group>. Zlivanje nuklearnomedicinskih in radioloških preiskav: PET/CT in SPECT/CT. In: Fras Z, Poredoš P, ur. Zbornik prispevkov: 53 Tavčarjevi dnevi; 3.-5. november 2011; Portorož, Slovenija. V Ljubljani : Medicinska fakulteta; <year>2011</year>. p. 329–37.</mixed-citation></ref>
<ref id="b7"><mixed-citation publication-type="book-chapter" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Lodge</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Frey</surname> <given-names>EC</given-names></string-name></person-group>. <chapter-title>Nuclear Medicine Imaging Devices</chapter-title>. In: <person-group person-group-type="editor"><string-name><surname>Bailey</surname> <given-names>DL</given-names></string-name>, <string-name><surname>Humm</surname> <given-names>JL</given-names></string-name>, <role>editors</role></person-group>. <source>Todd-Pokropek A, Aswegen Av, ur. Nuclear Medicine Physics: A Handbook for Teachers and Students. Dunaj</source>. <publisher-name>IAEA</publisher-name>; <year>2014</year>. pp. <fpage>312</fpage>–<lpage>97</lpage>.</mixed-citation></ref>
<ref id="b8"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Appetecchia</surname> <given-names>M</given-names></string-name>, <string-name><surname>Baldelli</surname> <given-names>R</given-names></string-name></person-group>. <article-title>Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives</article-title>. <source>J Exp Clin Cancer Res</source>. <year>2010</year> <month>Mar</month>;<volume>29</volume>(<issue>1</issue>):<fpage>19</fpage>. <pub-id pub-id-type="doi">10.1186/1756-9966-29-19</pub-id><pub-id pub-id-type="pmid">20196864</pub-id><issn>0392-9078</issn></mixed-citation></ref>
<ref id="b9"><mixed-citation publication-type="unknown" specific-use="unparsed"><person-group person-group-type="author"><string-name><surname>Moltara</surname> <given-names>ME</given-names></string-name>, <string-name><surname>Ocvirk</surname> <given-names>J</given-names></string-name></person-group>. <article-title>Nevroendokrini tumorji prebavil.</article-title> ONKOLOGIJA/pregledi. <year>2011</year>(2):88–92.</mixed-citation></ref>
<ref id="b10"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Reubi</surname> <given-names>JC</given-names></string-name></person-group>. <article-title>Peptide receptors as molecular targets for cancer diagnosis and therapy</article-title>. <source>Endocr Rev</source>. <year>2003</year> <month>Aug</month>;<volume>24</volume>(<issue>4</issue>):<fpage>389</fpage>–<lpage>427</lpage>. <pub-id pub-id-type="doi">10.1210/er.2002-0007</pub-id><pub-id pub-id-type="pmid">12920149</pub-id><issn>0163-769X</issn></mixed-citation></ref>
<ref id="b11"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Schottelius</surname> <given-names>M</given-names></string-name>, <string-name><surname>Wester</surname> <given-names>HJ</given-names></string-name></person-group>. <article-title>Molecular imaging targeting peptide receptors</article-title>. <source>Methods</source>. <year>2009</year> <month>Jun</month>;<volume>48</volume>(<issue>2</issue>):<fpage>161</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymeth.2009.03.012</pub-id><pub-id pub-id-type="pmid">19324088</pub-id><issn>1046-2023</issn></mixed-citation></ref>
<ref id="b12"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Maecke</surname> <given-names>HR</given-names></string-name>, <string-name><surname>Reubi</surname> <given-names>JC</given-names></string-name></person-group>. <article-title>Somatostatin receptors as targets for nuclear medicine imaging and radionuclide treatment</article-title>. <source>J Nucl Med</source>. <year>2011</year> <month>Jun</month>;<volume>52</volume>(<issue>6</issue>):<fpage>841</fpage>–<lpage>4</lpage>. <pub-id pub-id-type="doi">10.2967/jnumed.110.084236</pub-id><pub-id pub-id-type="pmid">21571797</pub-id><issn>0161-5505</issn></mixed-citation></ref>
<ref id="b13"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Gabriel</surname> <given-names>M</given-names></string-name>, <string-name><surname>Decristoforo</surname> <given-names>C</given-names></string-name>, <string-name><surname>Donnemiller</surname> <given-names>E</given-names></string-name>, <string-name><surname>Ulmer</surname> <given-names>H</given-names></string-name>, <string-name><surname>Watfah Rychlinski</surname> <given-names>C</given-names></string-name>, <string-name><surname>Mather</surname> <given-names>SJ</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors</article-title>. <source>J Nucl Med</source>. <year>2003</year> <month>May</month>;<volume>44</volume>(<issue>5</issue>):<fpage>708</fpage>–<lpage>16</lpage>.<pub-id pub-id-type="pmid">12732671</pub-id><issn>0161-5505</issn></mixed-citation></ref>
<ref id="b14"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Owyang</surname> <given-names>C</given-names></string-name>, <string-name><surname>Logsdon</surname> <given-names>CD</given-names></string-name></person-group>. <article-title>New insights into neurohormonal regulation of pancreatic secretion</article-title>. <source>Gastroenterology</source>. <year>2004</year> <month>Sep</month>;<volume>127</volume>(<issue>3</issue>):<fpage>957</fpage>–<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2004.05.002</pub-id><pub-id pub-id-type="pmid">15362050</pub-id><issn>0016-5085</issn></mixed-citation></ref>
<ref id="b15"><mixed-citation publication-type="unknown" specific-use="linked"><person-group person-group-type="author"><string-name><surname>Mutt</surname> <given-names>V.</given-names></string-name></person-group> <article-title>Secretin and cholecystokinin.</article-title> Gastrointestinal hormones. <year>1988</year>:251–320. <pub-id pub-id-type="doi">10.1016/B978-0-12-027311-9.50012-3</pub-id></mixed-citation></ref>
<ref id="b16"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Dufresne</surname> <given-names>M</given-names></string-name>, <string-name><surname>Seva</surname> <given-names>C</given-names></string-name>, <string-name><surname>Fourmy</surname> <given-names>D</given-names></string-name></person-group>. <article-title>Cholecystokinin and gastrin receptors</article-title>. <source>Physiol Rev</source>. <year>2006</year> <month>Jul</month>;<volume>86</volume>(<issue>3</issue>):<fpage>805</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00014.2005</pub-id><pub-id pub-id-type="pmid">16816139</pub-id><issn>0031-9333</issn></mixed-citation></ref>
<ref id="b17"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Reubi</surname> <given-names>JC</given-names></string-name>, <string-name><surname>Schaer</surname> <given-names>JC</given-names></string-name>, <string-name><surname>Waser</surname> <given-names>B</given-names></string-name></person-group>. <article-title>Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors</article-title>. <source>Cancer Res</source>. <year>1997</year> <month>Apr</month>;<volume>57</volume>(<issue>7</issue>):<fpage>1377</fpage>–<lpage>86</lpage>.<pub-id pub-id-type="pmid">9102227</pub-id><issn>0008-5472</issn></mixed-citation></ref>
<ref id="b18"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Charron</surname> <given-names>CL</given-names></string-name>, <string-name><surname>Hickey</surname> <given-names>JL</given-names></string-name>, <string-name><surname>Nsiama</surname> <given-names>TK</given-names></string-name>, <string-name><surname>Cruickshank</surname> <given-names>DR</given-names></string-name>, <string-name><surname>Turnbull</surname> <given-names>WL</given-names></string-name>, <string-name><surname>Luyt</surname> <given-names>LG</given-names></string-name></person-group>. <article-title>Molecular imaging probes derived from natural peptides</article-title>. <source>Nat Prod Rep</source>. <year>2016</year> <month>Jun</month>;<volume>33</volume>(<issue>6</issue>):<fpage>761</fpage>–<lpage>800</lpage>. <pub-id pub-id-type="doi">10.1039/C5NP00083A</pub-id><pub-id pub-id-type="pmid">26911790</pub-id><issn>0265-0568</issn></mixed-citation></ref>
<ref id="b19"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Matsumori</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Katakami</surname> <given-names>N</given-names></string-name>, <string-name><surname>Ito</surname> <given-names>M</given-names></string-name>, <string-name><surname>Taniguchi</surname> <given-names>T</given-names></string-name>, <string-name><surname>Iwata</surname> <given-names>N</given-names></string-name>, <string-name><surname>Takaishi</surname> <given-names>T</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Cholecystokinin-B/gastrin receptor: a novel molecular probe for human small cell lung cancer</article-title>. <source>Cancer Res</source>. <year>1995</year> <month>Jan</month>;<volume>55</volume>(<issue>2</issue>):<fpage>276</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="pmid">7812957</pub-id><issn>0008-5472</issn></mixed-citation></ref>
<ref id="b20"><mixed-citation publication-type="book" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Salavati</surname> <given-names>A</given-names></string-name>, <string-name><surname>Puranik</surname> <given-names>A</given-names></string-name>, <string-name><surname>Kulkarni</surname> <given-names>HR</given-names></string-name>, <string-name><surname>Budiawan</surname> <given-names>H</given-names></string-name>, <string-name><surname>Baum</surname> <given-names>RP</given-names></string-name></person-group>. <source>Peptide Receptor Radionuclide Therapy (PRRT) of Medullary and Nonmedullary Thyroid Cancer Using Radiolabeled Somatostatin Analogues. Semin Nucl Med</source>. <publisher-name>Elsevier</publisher-name>; <year>2016</year>. pp. <fpage>215</fpage>–<lpage>24</lpage>.</mixed-citation></ref>
<ref id="b21"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Saad</surname> <given-names>MF</given-names></string-name>, <string-name><surname>Ordonez</surname> <given-names>NG</given-names></string-name>, <string-name><surname>Rashid</surname> <given-names>RK</given-names></string-name>, <string-name><surname>Guido</surname> <given-names>JJ</given-names></string-name>, <string-name><surname>Hill</surname> <given-names>CS</given-names> <suffix>Jr</suffix></string-name>, <string-name><surname>Hickey</surname> <given-names>RC</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients</article-title>. <source>Medicine (Baltimore)</source>. <year>1984</year> <month>Nov</month>;<volume>63</volume>(<issue>6</issue>):<fpage>319</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1097/00005792-198411000-00001</pub-id><pub-id pub-id-type="pmid">6503683</pub-id><issn>0025-7974</issn></mixed-citation></ref>
<ref id="b22"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Šabani</surname> <given-names>M</given-names></string-name>, <string-name><surname>Jelovac</surname> <given-names>DB</given-names></string-name>, <string-name><surname>Petrović</surname> <given-names>MB</given-names></string-name>, <string-name><surname>Gavrić</surname> <given-names>M</given-names></string-name></person-group>. <article-title>Management of Advanced Medullary Thyroid Carcinoma</article-title>. <source>Journal of Tumor.</source> <year>2014</year>;<volume>2</volume>(<issue>8</issue>):<fpage>202</fpage>–<lpage>7</lpage>.</mixed-citation></ref>
<ref id="b23"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Wells</surname> <given-names>SA</given-names> <suffix>Jr</suffix></string-name>, <string-name><surname>Robinson</surname> <given-names>BG</given-names></string-name>, <string-name><surname>Gagel</surname> <given-names>RF</given-names></string-name>, <string-name><surname>Dralle</surname> <given-names>H</given-names></string-name>, <string-name><surname>Fagin</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Santoro</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial</article-title>. <source>J Clin Oncol</source>. <year>2012</year> <month>Jan</month>;<volume>30</volume>(<issue>2</issue>):<fpage>134</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1200/JCO.2011.35.5040</pub-id><pub-id pub-id-type="pmid">22025146</pub-id><issn>0732-183X</issn></mixed-citation></ref>
<ref id="b24"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Behr</surname> <given-names>TM</given-names></string-name>, <string-name><surname>Jenner</surname> <given-names>N</given-names></string-name>, <string-name><surname>Radetzky</surname> <given-names>S</given-names></string-name>, <string-name><surname>Béhe</surname> <given-names>M</given-names></string-name>, <string-name><surname>Gratz</surname> <given-names>S</given-names></string-name>, <string-name><surname>Yücekent</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Targeting of cholecystokinin-B/gastrin receptors in vivo: preclinical and initial clinical evaluation of the diagnostic and therapeutic potential of radiolabelled gastrin</article-title>. <source>Eur J Nucl Med</source>. <year>1998</year> <month>Apr</month>;<volume>25</volume>(<issue>4</issue>):<fpage>424</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1007/s002590050241</pub-id><pub-id pub-id-type="pmid">9553173</pub-id><issn>0340-6997</issn></mixed-citation></ref>
<ref id="b25"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Gotthardt</surname> <given-names>M</given-names></string-name>, <string-name><surname>Boermann</surname> <given-names>OC</given-names></string-name>, <string-name><surname>Behr</surname> <given-names>TM</given-names></string-name>, <string-name><surname>Béhé</surname> <given-names>MP</given-names></string-name>, <string-name><surname>Oyen</surname> <given-names>WJ</given-names></string-name></person-group>. <article-title>Development and clinical application of peptide-based radiopharmaceuticals</article-title>. <source>Curr Pharm Des</source>. <year>2004</year>;<volume>10</volume>(<issue>24</issue>):<fpage>2951</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.2174/1381612043383502</pub-id><pub-id pub-id-type="pmid">15379661</pub-id><issn>1381-6128</issn></mixed-citation></ref>
<ref id="b26"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Béhé</surname> <given-names>M</given-names></string-name>, <string-name><surname>Becker</surname> <given-names>W</given-names></string-name>, <string-name><surname>Gotthardt</surname> <given-names>M</given-names></string-name>, <string-name><surname>Angerstein</surname> <given-names>C</given-names></string-name>, <string-name><surname>Behr</surname> <given-names>TM</given-names></string-name></person-group>. <article-title>Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives</article-title>. <source>Eur J Nucl Med Mol Imaging</source>. <year>2003</year> <month>Aug</month>;<volume>30</volume>(<issue>8</issue>):<fpage>1140</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1007/s00259-003-1178-1</pub-id><pub-id pub-id-type="pmid">12768330</pub-id><issn>1619-7070</issn></mixed-citation></ref>
<ref id="b27"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Nock</surname> <given-names>BA</given-names></string-name>, <string-name><surname>Maina</surname> <given-names>T</given-names></string-name>, <string-name><surname>Béhé</surname> <given-names>M</given-names></string-name>, <string-name><surname>Nikolopoulou</surname> <given-names>A</given-names></string-name>, <string-name><surname>Gotthardt</surname> <given-names>M</given-names></string-name>, <string-name><surname>Schmitt</surname> <given-names>JS</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>CCK-2/gastrin receptor-targeted tumor imaging with (99m)Tc-labeled minigastrin analogs</article-title>. <source>J Nucl Med</source>. <year>2005</year> <month>Oct</month>;<volume>46</volume>(<issue>10</issue>):<fpage>1727</fpage>–<lpage>36</lpage>.<pub-id pub-id-type="pmid">16204724</pub-id><issn>0161-5505</issn></mixed-citation></ref>
<ref id="b28"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>von Guggenberg</surname> <given-names>E</given-names></string-name>, <string-name><surname>Sallegger</surname> <given-names>W</given-names></string-name>, <string-name><surname>Helbok</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ocak</surname> <given-names>M</given-names></string-name>, <string-name><surname>King</surname> <given-names>R</given-names></string-name>, <string-name><surname>Mather</surname> <given-names>SJ</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Cyclic minigastrin analogues for gastrin receptor scintigraphy with technetium-99m: preclinical evaluation</article-title>. <source>J Med Chem</source>. <year>2009</year> <month>Aug</month>;<volume>52</volume>(<issue>15</issue>):<fpage>4786</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1021/jm900400w</pub-id><pub-id pub-id-type="pmid">19591486</pub-id><issn>0022-2623</issn></mixed-citation></ref>
<ref id="b29"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Kolenc-Peitl</surname> <given-names>P</given-names></string-name>, <string-name><surname>Mansi</surname> <given-names>R</given-names></string-name>, <string-name><surname>Tamma</surname> <given-names>M</given-names></string-name>, <string-name><surname>Gmeiner-Stopar</surname> <given-names>T</given-names></string-name>, <string-name><surname>Sollner-Dolenc</surname> <given-names>M</given-names></string-name>, <string-name><surname>Waser</surname> <given-names>B</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Highly improved metabolic stability and pharmacokinetics of indium-111-DOTA-gastrin conjugates for targeting of the gastrin receptor</article-title>. <source>J Med Chem</source>. <year>2011</year> <month>Apr</month>;<volume>54</volume>(<issue>8</issue>):<fpage>2602</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1021/jm101279a</pub-id><pub-id pub-id-type="pmid">21456601</pub-id><issn>0022-2623</issn></mixed-citation></ref>
<ref id="b30"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Aloj</surname> <given-names>L</given-names></string-name>, <string-name><surname>Aurilio</surname> <given-names>M</given-names></string-name>, <string-name><surname>Rinaldi</surname> <given-names>V</given-names></string-name>, <string-name><surname>D’Ambrosio</surname> <given-names>L</given-names></string-name>, <string-name><surname>Tesauro</surname> <given-names>D</given-names></string-name>, <string-name><surname>Peitl</surname> <given-names>PK</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Comparison of the binding and internalization properties of 12 DOTA-coupled and (1)(1)(1)In-labelled CCK2/gastrin receptor binding peptides: a collaborative project under COST Action BM0607</article-title>. <source>Eur J Nucl Med Mol Imaging</source>. <year>2011</year>;<volume>38</volume>(<issue>8</issue>):<fpage>1417</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1007/s00259-011-1816-y</pub-id><pub-id pub-id-type="pmid">21523391</pub-id><issn>1619-7070</issn></mixed-citation></ref>
<ref id="b31"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Laverman</surname> <given-names>P</given-names></string-name>, <string-name><surname>Joosten</surname> <given-names>L</given-names></string-name>, <string-name><surname>Eek</surname> <given-names>A</given-names></string-name>, <string-name><surname>Roosenburg</surname> <given-names>S</given-names></string-name>, <string-name><surname>Peitl</surname> <given-names>PK</given-names></string-name>, <string-name><surname>Maina</surname> <given-names>T</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Comparative biodistribution of 12 (1)(1)(1)In-labelled gastrin/CCK2 receptor-targeting peptides</article-title>. <source>Eur J Nucl Med Mol Imaging</source>. <year>2011</year>;<volume>38</volume>(<issue>8</issue>):<fpage>1410</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1007/s00259-011-1806-0</pub-id><pub-id pub-id-type="pmid">21461732</pub-id><issn>1619-7070</issn></mixed-citation></ref>
<ref id="b32"><mixed-citation publication-type="journal" specific-use="restruct"><person-group person-group-type="author"><string-name><surname>Ocak</surname> <given-names>M</given-names></string-name>, <string-name><surname>Helbok</surname> <given-names>A</given-names></string-name>, <string-name><surname>Rangger</surname> <given-names>C</given-names></string-name>, <string-name><surname>Peitl</surname> <given-names>PK</given-names></string-name>, <string-name><surname>Nock</surname> <given-names>BA</given-names></string-name>, <string-name><surname>Morelli</surname> <given-names>G</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607</article-title>. <source>Eur J Nucl Med Mol Imaging</source>. <year>2011</year> <month>Aug</month>;<volume>38</volume>(<issue>8</issue>):<fpage>1426</fpage>–<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1007/s00259-011-1818-9</pub-id><pub-id pub-id-type="pmid">21528387</pub-id><issn>1619-7070</issn></mixed-citation></ref>
</ref-list>
</back>
</article>
